Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
J S James studies the pharmacological effects of synthetic cannabinoid receptor agonists, particularly their interaction with fentanyl and naloxone. Recent publications investigate how these synthetic compounds can exacerbate fentanyl-induced respiratory depression and reduce the effectiveness of naloxone in reversing overdoses in animal models. This research aims to understand potential mechanisms behind "Narcan-resistant" overdoses. James collaborates with researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi, Brenda M. Gannon, Hannah Shaw, and Jeffery H. Moran, with whom they have co-authored multiple publications. James's scholarly output includes four publications with an h-index of 2 and 11 total citations.
Metrics
- h-index: 2
- Publications: 4
- Citations: 12
Selected Publications
-
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)
-
Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose (2024)
Collaboration Network
Top Collaborators
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Similar Researchers
Based on overlapping research topics